CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)

Amomum subulatum
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

CardaMind is Akay Bioactives' full-spectrum water extract of black cardamom fruit (Amomum subulatum), coded MA2-24. Black cardamom is a different plant from green cardamom (Elettaria cardamomum), and the two have distinct chemical profiles. One randomized, double-blind trial in 96 working adults aged 35 to 65 who reported fatigue compared 250 mg of the extract once daily with placebo, 200 mg of caffeine, and the two combined, for 14 days. The extract beat placebo on computerized attention, processing-speed and Stroop tests, mostly 1 to 3 hours after a dose, and by day 14 most differences lasted to 5 hours. Caffeine produced larger changes on several measures, and the combination showed the most differences from placebo at the 5 and 8 hour checks. Two papers report the trial and differ on some first-day results. The maker funded it, and three authors work for the maker. Amount studied: 250 mg once daily.

Studied Dose 250 mg once daily, taken as a sachet dissolved in water, for up to 14 days (the only dose tested in people).
Active Compound Full-spectrum aqueous (water) extract of black cardamom (Amomum subulatum Roxb.) fruit, coded MA2-24; described in the trial report as more than 25% saponins with at least 2.5% 1,8-cineole plus polyphenols and flavonoids.

Benefits

Faster, more accurate attention-test scores 1 to 3 hours after a dose

In a randomized, double-blind trial of 96 working adults aged 35 to 65, 250 mg of the extract in water beat placebo on reaction time, correct answers and errors in computerized attention, symbol-coding and Stroop tests at 1 and 3 hours on the first day (p<0.05). The trial's later paper found fewer first-day differences. Caffeine (200 mg) produced larger changes on several measures. The maker funded the trial.

Attention and processing-speed gains held over 14 days of daily use

In the same trial, people took one sachet a day for 14 days, and 85 of 96 finished. On day 14 the extract still beat placebo on attention, symbol-coding and Stroop tests at 1, 3 and 5 hours, and on some of them at 8 hours. These are laboratory test scores in working adults, not measures of work, study or driving performance.

With caffeine, the combination kept attention-test gains the longest

In the same trial, the group taking the extract with 200 mg of caffeine showed the most differences from placebo at the 5 and 8 hour checks, especially on day 14. The papers compared each group with placebo and did not test whether the combined effect was more than the two added together. No caffeine crash or comedown was measured.

Mechanism of action

1

Proposed effects on brain signaling and oxidative stress

The trial authors propose that saponins, polyphenols and 1,8-cineole in the extract act on brain signaling chemicals such as acetylcholine and on oxidative stress, citing laboratory and animal research. Neither trial paper measured any blood or brain marker, so why the test scores changed is unknown.

2

BDNF and brain protection claims

No study cited on this page measured BDNF, neurotransmitters or brain protection in people. In one animal study, a methanol extract of black cardamom fruit (not this branded water extract) lowered oxidative stress and inflammation markers in the liver, kidneys and lungs after the drug methotrexate. It did not look at the brain.

3

Why the combination with caffeine lasted longer

The extract plus caffeine group differed from placebo at later time points than either alone. Why is not known. The first trial paper suggests the extract may slow caffeine breakdown (CYP1A2), but neither paper measured caffeine levels, and neither tested whether the combined effect was more than additive.

4

Water extraction and how black cardamom differs from green

The maker uses a water-based extraction; the first trial paper calls MA2-24 patented and the second calls it patent pending. A lab comparison found distinct chemical profiles in black and green cardamom seed and husk, so research on green cardamom does not transfer to this extract.

Clinical trials

1
Black cardamom extract MA2-24 versus placebo and caffeine for 14 days in 96 healthy adults
PubMed

Randomized, double-blind, placebo- and active-controlled, four-arm parallel trial (registry CTRI/2024/09/074472) of 250 mg MA2-24 (CardaMind) once daily for 14 days, with CNS Vital Signs tests at 1, 3, 5 and 8 hours after the dose on days 1, 7 and 14. The day 1 results were published first as a separate paper under the same registry number with the same 96 participants and product batches, so both papers describe one trial; their day 1 statistics differ. Funded by Akay Natural Ingredients, the maker; three authors are Akay employees and the first author works for a clinical research company. (Thomas et al. 2026, Front Neurosci)

96 working adults aged 35 to 65 (59 men, 37 women) with a Fatigue Severity Scale score above 4, 24 per group: placebo, 250 mg extract, 200 mg caffeine, or extract plus caffeine. 85 completed the 14 days.

On day 1 the first paper reports the extract beat placebo on attention, symbol-coding and Stroop scores at 1 and 3 hours (p<0.05), with caffeine larger on several measures; the 14-day paper's own day 1 analysis found no extract effect on attention-test errors at 1 and 3 hours or on Stroop at 3 hours. By day 14 the extract beat placebo on all seven scores at 1, 3 and 5 hours and on four at 8 hours. The extract plus caffeine showed the most differences from placebo at 5 and 8 hours. No adverse events were reported with the extract alone.

Side effects and drug interactions

Common Potential side effects

In the 14-day trial, no adverse events were reported in the 250 mg extract group. Across all four groups, 17 of 96 people reported 22 adverse events, mostly in the caffeine group (12 of 24); the authors describe all of them as mild and resolved.
The two trial papers give different side-effect counts for the caffeine arm (72% reporting discomfort in the day 1 paper, 50% in the 14-day paper). Products that pair this extract with caffeine can cause caffeine side effects such as a faster heart rate, stomach upset and poor sleep.
Human safety data cover only 14 days in healthy adults aged 35 to 65, from one maker-funded trial. Longer use, children and older adults have not been studied.
Black cardamom is a culinary spice, but food use does not establish the safety of a concentrated daily extract.
Pregnancy and breastfeeding: this extract has not been studied. The US LactMed database entry on cardamom covers green cardamom, not black, and found no published data on cardamom levels in breast milk or effects in breastfed infants. Ask a clinician before use.

Important Drug interactions

Caffeine: the two were taken together for 14 days in the trial; 4 of 24 people in the combination group reported mild adverse events, versus none with the extract alone. Count the caffeine in any combination product toward your daily total.
Stimulant medications (such as ADHD drugs or modafinil), memory medications and antidepressants: no interaction studies exist for this extract. Talk to your prescriber.
No drug interactions have been documented, but the only human data come from 14 days of use in healthy adults.

Frequently asked questions about CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)

Is CardaMind the same as green cardamom?

No. CardaMind is made from black cardamom (Amomum subulatum), a different plant from the green cardamom (Elettaria cardamomum) sold as a common baking spice. A laboratory comparison found the two have distinct chemical profiles. Research on green cardamom does not apply to this extract, and the CardaMind trial does not apply to green cardamom.

Can CardaMind replace caffeine?

The trial does not show that. In 96 adults, 200 mg of caffeine produced larger changes than 250 mg of the extract on several attention and processing-speed tests, and the most later-hour differences from placebo came from taking the two together. No adverse events were reported with the extract alone, while half of the caffeine group reported mild ones (72% in the first-day paper). The trial did not measure a caffeine crash.

Is CardaMind safe, and does it have side effects?

In the only human trial, 14 days of 250 mg a day in 96 healthy adults aged 35 to 65, no adverse events were reported in the extract-only group; side effects came mainly from caffeine. That is one short, maker-funded study, so longer use, pregnancy, breastfeeding, children and people taking medication have not been studied. Check with a healthcare provider first.

What is CardaMind?

CardaMind is Akay Bioactives' full-spectrum water extract of black cardamom fruit (Amomum subulatum), coded MA2-24. Black cardamom is a different plant from green cardamom (Elettaria cardamomum), and the two have distinct chemical profiles.

What is CardaMind used for?

CardaMind is researched primarily for Cognitive. In a randomized, double-blind trial of 96 working adults aged 35 to 65, 250 mg of the extract in water beat placebo on reaction time, correct answers and errors in computerized attention, symbol-coding and Stroop tests at 1 and 3 hours on t…

What is the recommended dosage of CardaMind?

The clinically studied dose is 250 mg once daily, taken as a sachet dissolved in water, for up to 14 days (the only dose tested in people). Always follow the product label and check with a healthcare provider for personal advice.

Does CardaMind interact with any medications?

Possible interactions include: Caffeine: the two were taken together for 14 days in the trial; 4 of 24 people in the combination group reported mild adverse events, versus none with the extract alone. Count the caffeine in any combination product toward your daily total. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for CardaMind?

NutraSmarts rates the evidence for CardaMind as Limited (2 out of 5). It is backed by 1 study summary and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Thomas JV, Mohan ME, Das SS, Allimuthu N, Devasia S, Aneesa PA, Madhavamenon KI, Sasidharan BCP. A full-spectrum aqueous extract of black cardamom (Amomum subulatum) improves focus/alertness and executive function: a randomized, double-blinded, placebo- and active-controlled, comparative study in healthy working-class participants. Front Neurosci. 2026;20:1786880. doi: 10.3389/fnins.2026.1786880.PubMedUsed to support: Day 1 report of the registered MA2-24 (CardaMind) trial: 96 healthy adults aged 35 to 65, 24 per group, given placebo, 250 mg extract, 200 mg caffeine, or both. The extract improved attention, symbol-coding and Stroop scores versus placebo mainly through 3 hours; caffeine reduced attention-test reaction time more than the extract at 1 and 3 hours; the combination gave more sustained effects at 5 to 8 hours. Funded by Akay Natural Ingredients; three authors are Akay employees. The authors list the single-dose design as a limitation.
  2. Thomas JV, Mohan ME, Das SS, Allimuthu N, Devasia S, Aneesa PA, Madhavamenon KI, Sasidharan BCP. Influence of a full-spectrum aqueous extract of black cardamom (Amomum subulatum Roxb.) fruits on focus/alertness and executive function: a randomized, double-blind, placebo-and active- controlled, 14-day comparative study in healthy working professionals. Front Neurosci. 2026;20:1879347. doi: 10.3389/fnins.2026.1879347.PubMedUsed to support: Full 14-day report of the same registered trial (CTRI/2024/09/074472, same 96 participants): 250 mg once daily beat placebo on attention, processing-speed and Stroop measures, mostly at 1 to 3 hours and through 5 hours on several tests by day 14; caffeine produced larger changes on several measures; the combination did best at 5 to 8 hours. 85 of 96 completed. No adverse events in the extract group; 12 of 24 in the caffeine group reported mild events. Maker funded, with three Akay-employed authors.
  3. Farrag AFS, Otify AM, Khedr AIM, Misnan NM, Mediani A, Wessjohann LA, Sharaf El-Din MG, Farag MA. Unveiling metabolome heterogeneity in seed and husk from three cardamom species for quality control and valorization purposes of its waste products via NMR-based metabolomics in relation to in vitro biological effects. Food Chem. 2025;480:143687. doi: 10.1016/j.foodchem.2025.143687.PubMedUsed to support: Laboratory (NMR) comparison of green (Elettaria cardamomum), black (Amomum subulatum) and white (Aframomum corrorima) cardamom seed and husk: the three species had distinct metabolite profiles. Supports the statement that black and green cardamom are chemically different plants; it is not a human study.
  4. Kumar A, Kumar SS. A comprehensive review on phytoconstituents, health benefits and post-harvest processing of Amomum subulatum Roxb. J Food Sci Technol. 2026;63(3):401-417. doi: 10.1007/s13197-025-06516-4.PubMedUsed to support: Review of black cardamom: a Himalayan cash crop with traditional uses, 27 identified compounds including flavonoids, chalconoids, phenolics, alkaloids and fatty acid esters, and reported pharmacological activities including antioxidant and anti-inflammatory effects. Background on the plant only; it is not a study of this extract.
  5. Drishya S, Dhanisha SS, Guruvayoorappan C. Antioxidant-rich fraction of Amomum subulatum fruits mitigates experimental methotrexate-induced oxidative stress by regulating TNF-α, IL-1β, and IL-6 proinflammatory cytokines. J Food Biochem. 2022;46(4):e13855. doi: 10.1111/jfbc.13855.PubMedUsed to support: Animal and test-tube study of a methanol extract of black cardamom fruit (not the branded water extract): it scavenged free radicals in vitro and, given with methotrexate in vivo, reduced liver, kidney and lung toxicity markers and TNF-alpha, IL-1beta and IL-6. It did not study the brain, cognition or people.
  6. National Institute of Child Health and Human Development. Cardamom. Drugs and Lactation Database (LactMed®). 2025;Bethesda (MD): National Institute of Child Health and Human Development; 2006 onward. Last revision May 15, 2025. NCBI Bookshelf NBK615240..PubMedUsed to support: US government lactation database entry on cardamom, which covers green cardamom (Elettaria cardamomum), not black cardamom. It found no published data on maternal or infant levels or on effects in breastfed infants; it describes one trial of a four-herb mixture containing 0.5 g cardamom per dose in breastfeeding mothers.